{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:41:17Z","timestamp":1740120077074,"version":"3.37.3"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.trim.2024.102110","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T17:01:12Z","timestamp":1725037272000},"page":"102110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Early tocilizumab treatment was associated with survival benefits in hospitalized kidney transplants with severe COVID-19 infection: A prospective cohort study"],"prefix":"10.1016","volume":"87","author":[{"given":"Yangming","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saifu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haohan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turun","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2024.102110_bb0005","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.kint.2020.10.008","article-title":"IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)","volume":"98","author":"Thaunat","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.trim.2024.102110_bb0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.trim.2024.102110_bb0015","doi-asserted-by":"crossref","first-page":"22351","DOI":"10.1073\/pnas.2010229117","article-title":"IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome","volume":"117","author":"Kang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.trim.2024.102110_bb0020","article-title":"The IL-1\u03b2, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19","volume":"3","author":"Schulthei\u00df","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.trim.2024.102110_bb0025","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41577-021-00553-8","article-title":"Is IL-6 a key cytokine target for therapy in COVID-19?","volume":"21","author":"Jones","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trim.2024.102110_bb0030","article-title":"Upregulated IL-6 indicates a poor COVID-19 prognosis: a call for tocilizumab and convalescent plasma treatment","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2024.102110_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.09.018","article-title":"IL-6 serum levels predict severity and response to tocilizumab in COVID-19: an observational study","volume":"147","author":"Galv\u00e1n-Rom\u00e1n","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.trim.2024.102110_bb0040","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1200\/JCO.20.02477","article-title":"Risk-adapted preemptive tocilizumab to prevent severe cytokine release syndrome after CTL019 for pediatric B-cell acute lymphoblastic leukemia: a prospective clinical trial","volume":"39","author":"Kadauke","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trim.2024.102110_bb0045","article-title":"Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study","volume":"364","author":"Gottenberg","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.trim.2024.102110_bb0050","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1111\/ajt.16080","article-title":"Tocilizumab therapy in 5 solid and composite tissue transplant recipients with early ARDS due to SARS-CoV-2","volume":"20","author":"Morillas","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2024.102110_bb0055","article-title":"Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study","volume":"20","author":"Mr","year":"2020","journal-title":"Am. J. Transpl.: Off. J. Am. Soc. Transpl. Am. Soc. Transpl. Surg."},{"key":"10.1016\/j.trim.2024.102110_bb0060","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1111\/ajt.16192","article-title":"Use of tocilizumab in kidney transplant recipients with COVID-19","volume":"20","author":"P\u00e9rez-S\u00e1ez","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2024.102110_bb0065","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1111\/ajt.15985","article-title":"Clinical course of COVID-19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: a case report","volume":"20","author":"Hammami","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2024.102110_bb0070","first-page":"787","article-title":"Impact of Nirmatrelvir-ritonavir on tacrolimus concentrations","author":"S F","year":"2022","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2024.102110_bb0075","article-title":"Optimizing the use of nirmatrelvir\/ritonavir in solid organ transplant recipients with COVID-19: a review of immunosuppressant adjustment strategies","volume":"14","author":"Tang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2024.102110_bb0080","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","article-title":"Tocilizumab in hospitalized patients with severe Covid-19 pneumonia","volume":"384","author":"Rosas","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2024.102110_bb0085","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/qjmed\/hcaa206","article-title":"Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case-controlled study","volume":"113","author":"Rojas-Marte","year":"2020","journal-title":"QJM"},{"key":"10.1016\/j.trim.2024.102110_bb0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jamainternmed.2020.6252","article-title":"Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19","volume":"181","author":"Gupta","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.trim.2024.102110_bb0095","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.trim.2024.102110_bb0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/10781552211052635","article-title":"The impact of early versus late tocilizumab administration in patients with cytokine release syndrome secondary to immune effector cell therapy","volume":"29","author":"Peaytt","year":"2023","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.trim.2024.102110_bb0105","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1158\/2159-8290.CD-16-0040","article-title":"Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia","volume":"6","author":"Teachey","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trim.2024.102110_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.idnow.2021.06.304","article-title":"Tocilizumab and COVID-19: timing of administration assessment","volume":"52","author":"Richier","year":"2022","journal-title":"Infect. Dis. Now."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327424001266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327424001266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T03:53:44Z","timestamp":1732593224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327424001266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":22,"alternative-id":["S0966327424001266"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2024.102110","relation":{},"ISSN":["0966-3274"],"issn-type":[{"type":"print","value":"0966-3274"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early tocilizumab treatment was associated with survival benefits in hospitalized kidney transplants with severe COVID-19 infection: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2024.102110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102110"}}